Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 14, 2026; 32(14): 114331
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.114331
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.114331
Figure 4 Interferon-γ, tumor necrosis factor-α, interleukin-1β, and interleukin-18 secreted were increased in correlation with the concentration of Xiangshaliujunzi decoction in BGC-823/5-fluorouracil cells treated with Xiangshaliujunzi decoction.
A: Interferon-γ; B: Tumor necrosis factor-α; C: Interleukin (IL)-1β; D: IL-18. L-Xiangshaliujunzi decoction (XSLJZD): 1.55 g/(kg·day); M-XSLJZD: 3.1 g/(kg·day); H- XSLJZD: 6.2 g/(kg·day). aP < 0.05, bP < 0.01, cP < 0.001 vs control. XSLJZD: Xiangshaliujunzi decoction; IFN: Interferon; TNF: Tumor necrosis factor; IL: Interleukin.
- Citation: Gao H, Yin DF, Xing XR, Zhou LJ, Yu R. MiR-200a-3p/ZEB1/IRF1-mediated PANoptosis prompts Xiangshaliujunzi decoction to overcome 5-fluorouracil resistance in gastric cancer. World J Gastroenterol 2026; 32(14): 114331
- URL: https://www.wjgnet.com/1007-9327/full/v32/i14/114331.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i14.114331